aTyr Pharma | LIFE - Ordinary Share Capital


aTyr Pharma reported $97.99M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 213.97M 144.39K Jun/2023
Ardelyx USD 238.02M 1.13M Dec/2024
aTyr Pharma USD 97.99M 97.9M Sep/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cipla INR 807.77M 807.43M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 3.99M Jun/2025
CSL USD 576M 19M Dec/2024
Curis USD 59K 934K Sep/2023
Galapagos EUR 65.9M 0 Sep/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Grifols EUR 679.73M 0 Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
Xoma USD 87K 1000 Jun/2024